Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Buy

Security Buy Sell Buy (1M) Sell (1M) ▲ Price Target price Potential
Intra-Cellular Therapies Inc. 23 0 6 0 €64.00 €79.43 24.109%
Akebia Therapeutics Inc. 8 3 1 0 €1.28 €3.60 181.840%
Aldeyra Therapeutics Inc. 2 0 0 0 €3.87 - -
Affimed N.V. 8 6 0 0 €0.55 €6.54 1083.165%
Abeona Therapeutics Inc. 3 1 1 0 €4.28 €34.41 704.033%
M1 Kliniken AG 2 0 0 0 €15.75 - -
EyePoint Pharmaceuticals Inc. 14 1 0 1 €18.33 €28.17 53.670%
X4 Pharmaceuticals, Inc. 6 1 3 1 €1.07 €2.78 158.705%
Insmed Inc. 13 1 2 1 €23.60 €44.01 86.469%
Syros Pharmaceuticals Inc. 5 1 1 1 €4.78 €12.80 167.814%
Ocular Therapeutix Inc. 7 5 0 1 €5.73 €11.40 98.980%
Addus Homecare Corp. 11 1 0 1 €90.00 €98.14 9.047%
Fate Therapeutics Inc. 5 2 2 1 €3.78 €8.27 118.625%
Enanta Pharmaceuticals Inc. 5 4 0 1 €13.90 €26.92 93.694%
Immunic Inc. 6 3 0 2 €1.23 €5.48 345.313%